Global status report on noncommunicable diseases 2014. Available from: http://www.who.int/nmh/publications/ncd-status-report-2014/en/index-html.
Global action plan for the prevention and control of NCDs 2013-2020.
Association of age and sex with myocardial infarction symptom presentation and in-hospital mortality. JAMA 2012 Feb;307(8):813-822.
Sex differences in lifetime risk and first manifestation of cardiovascular disease, prospective population based Cohort study. BMJ 2014 Nov;349.
Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA 1998 Aug;280(7):605-613.
Combined postmenopausal hormone therapy and cardiovascular disease: toward resolving the discrepancy between observational studies and the Women’s Health Initiative clinical trial. Am J Epidemiol 2005 Sep 1;162(5):404-414.
Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trial. JAMA 2002 Jul 17;288(3):321-333.
2016 IMS Recommendations on women’s midlife health and menopause hormone therapy. Climacteric 2016 Apr;19(2):109-150.
